Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023)

References

• Armenteras D. Guidelines for healthy global scientific collaborations. Nat Ecol Evol. 2021;5(9):1193–23. doi:10.1038/s41559-021-01496-y.
   PubMed Web of Science ®Google Scholar
• Shen H, Xie J, Li J, Cheng Y. The correlation between scientific collaboration and citation count at the paper level: a meta-analysis. Scientometrics. 2021;126(4):443–70. doi:10.1007/s11192-021-03888-0.
   Web of Science ®Google Scholar
• Lu W, Ren Y, Huang Y, Bu Y, Zhang Y. Scientific collaboration and career stages: an ego-centric perspective. J Informetr. 2021;15(4):101207. doi:10.1016/j.joi.2021.101207.
   Web of Science ®Google Scholar
• Druedahl LC, Minssen T, Price WN. Collaboration in times of crisis: a study on COVID-19 vaccine R&D partnerships. Vaccine. 2021;39(42):6291–5. doi:10.1016/j.vaccine.2021.08.101.
   PubMed Web of Science ®Google Scholar
• Fry CV, Cai X, Zhang Y, Wagner CS. Consolidation in a crisis: patterns of international collaboration in early COVID-19 research. PloS One. 2020;15(7):e36307. doi:10.1371/journal.pone.0236307.
   Web of Science ®Google Scholar
• Wang J, Hong N. The COVID-19 research landscape measuring topics and collaborations using scientific literature. Medicine. 2020;99(43):e22849. doi:10.1097/MD.0000000000022849.
   PubMed Web of Science ®Google Scholar
• Chernysh Y, Roubik H. International collaboration in the field of environmental protection: trend analysis and COVID-19 implications. Sustain Basel. 2020;12(24):1–18. doi:10.3390/su122410384.
   PubMed Web of Science ®Google Scholar
• Zaer H, Fan W, Orlowski D, Glud AN, Andersen ASM, Schneider MB, Adler JR, Stroh A, Sørensen JCH. A perspective of international collaboration through Web-based telecommunication–inspired by COVID-19 crisis. Front Hum Neurosci. 2020;14:577465. doi:10.3389/fnhum.2020.577465.
   PubMed Web of Science ®Google Scholar
• Cordato DJJ, Shad KF, Soubra W, Beran RGG. Health research and education during and after the COVID-19 pandemic: an Australian clinician and researcher perspective. Diagnostics. 2023;13(2):289–300. doi:10.3390/diagnostics13020289.
   Web of Science ®Google Scholar
• Guimon J, Narula R. Ending the COVID-19 pandemic requires more international collaboration. Res Technol Manage. 2020;63(5):438–41. doi:10.1080/08956308.2020.1790239.
   Web of Science ®Google Scholar
• Kim K, Cho KT. A review of global collaboration on COVID-19 research during the pandemic in 2020. Sustain Basel. 2021;13(14):7618. doi:10.3390/su13147618.
   Web of Science ®Google Scholar
• Cai X, Fry CV, Wagner CS. International collaboration during the COVID-19 crisis: autumn 2020 developments. Scientometrics. 2021;126(4):3683–92. doi:10.1007/s11192-021-03873-7.
   PubMed Web of Science ®Google Scholar
• Vervoort D, Ma X, Luc JGY. COVID-19 pandemic: a time for collaboration and a unified global health front. Int J Qual Health Care. 2021;33(1):mzaa65. doi:10.1093/intqhc/mzaa065.
   Web of Science ®Google Scholar
• Malekpour M, Abbasi-Kangevari M, Azadnajafabad S, Ghamari S-H, Rezaei N, Rezazadeh-Khadem S, Rezaei N, Aminorroaya A, Abdolhamidi E, Mohammadi Fateh S, et al. How the scientific community responded to the COVID-19 pandemic: a subject-level time-trend bibliometric analysis. PloS One. 2021;16(9):e258064. doi:10.1371/journal.pone.0258064.
   Web of Science ®Google Scholar
• Thavorn J, Gowanit C, Muangsin V, Muangsin N. Collaboration network and trends of global coronavirus disease research: a scientometric analysis. IEEE Access. 2021;9:45001–16. doi:10.1109/ACCESS.2021.3066450.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New Engl J Med. 2020;383(27):2603–15. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Hajissa K, Mussa A. Positive aspects of the mRNA platform for SARS-CoV-2 vaccines. Hum Vacc Immunother. 2021;17(8):2445–7. doi:10.1080/21645515.2021.1900713.
   PubMed Web of Science ®Google Scholar
• Baden LR, El HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New Engl J Med. 2021;384(5):403–16. doi:10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Chen P, Shi X, He W, Zhong G, Tang Y, Wang H, Zhang P. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic. Hum Vaccin Immunother. 2022;18(1):2040330. doi:10.1080/21645515.2022.2040330.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang T, Lu Y, Yang X, Ouyang Z. Emerging trends of research on mRNA vaccines: a co-citation analysis. Hum Vacc Immunother. 2022;18(6):2110409. doi:10.1080/21645515.2022.2110409.
   PubMed Web of Science ®Google Scholar
• Kariko K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther. 2008;16(11):1833–40. doi:10.1038/mt.2008.200.
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247(4949 Pt 1):1465–8. doi:10.1126/science.1690918.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261–79. doi:10.1038/nrd.2017.243.
   PubMed Web of Science ®Google Scholar
• Sahin U, Kariko K, Tureci O. mRNA-based therapeutics–developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–80. doi:10.1038/nrd4278.
   PubMed Web of Science ®Google Scholar
• Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J Control Release. 2015;217:345–51. doi:10.1016/j.jconrel.2015.08.007.
   PubMed Web of Science ®Google Scholar
• Vogel AB, Lambert L, Kinnear E, Busse D, Erbar S, Reuter KC, Wicke L, Perkovic M, Beissert T, Haas H, et al. Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses. Mol Ther. 2018;26(2):446–55. doi:10.1016/j.ymthe.2017.11.017.
   PubMed Web of Science ®Google Scholar
• Hekele A, Bertholet S, Archer J, Gibson DG, Palladino G, Brito LA, Otten GR, Brazzoli M, Buccato S, Bonci A, et al. Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infec. 2013;2(1):1–7. doi:10.1038/emi.2013.54.
   PubMed Web of Science ®Google Scholar
• Geall AJ, Verma A, Otten GR, Shaw CA, Hekele A, Banerjee K, Cu Y, Beard CW, Brito LA, Krucker T, et al. Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci USA. 2012;109(36):14604–9. doi:10.1073/pnas.1209367109.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, et al. An mRNA vaccine against SARS-CoV-2 – preliminary report. N Engl J Med. 2020;383(20):1920–31. doi:10.1056/NEJMoa2022483.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, et al. Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. New Engl J Med. 2020;383(25):2439–50. doi:10.1056/NEJMoa2027906.
   PubMed Web of Science ®Google Scholar
• Abramo G, D’Angelo CA, Di Costa F. How the COVID-19 crisis shaped research collaboration behaviour. Scientometrics. 2022;127(8):5053–71. doi:10.1007/s11192-022-04450-2.
   Web of Science ®Google Scholar
• Li Y, Li H, Liu N, Liu X. Important institutions of inter institutional scientific collaboration networks in materials science. Scientometrics. 2018;117(1):85–103. doi:10.1007/s11192-018-2837-0.
   Web of Science ®Google Scholar
• Fu YC, Marques M, Tseng Y, Powell JJW, Baker DP. An evolving international research collaboration network: spatial and thematic developments in co-authored higher education research, 1998–2018. Scientometrics. 2022;127(3):1403–29. doi:10.1007/s11192-021-04200-w.
   Web of Science ®Google Scholar
• Aksnes DW, Piro FN, Rorstad K. Gender gaps in international research collaboration: a bibliometric approach. Scientometrics. 2019;120(2):747–74. doi:10.1007/s11192-019-03155-3.
   Web of Science ®Google Scholar
• Essers D, Grigoli F, Pugacheva E. Network effects and research collaborations: evidence from IMF working paper co-authorship. Scientometrics. 2022;127(12):357–68. doi:10.1007/s11192-022-04335-4.
   Web of Science ®Google Scholar
• Harzing A, Alakangas S. Google scholar, Scopus and the Web of science: a longitudinal and cross-disciplinary comparison. Scientometrics. 2016;106(2):787–804. doi:10.1007/s11192-015-1798-9.
   Web of Science ®Google Scholar
• Mongeon P, Paul-Hus A. The journal coverage of web of science and Scopus: a comparative analysis. Scientometrics. 2016;106(1):213–28. doi:10.1007/s11192-015-1765-5.
   Web of Science ®Google Scholar
• Niu F, Qiu J. Network structure, distribution and the growth of Chinese international research collaboration. Scientometrics. 2014;98(2):1221–33. doi:10.1007/s11192-013-1170-x.
   Web of Science ®Google Scholar
• Fonkou MDM, Bragazzi NL, Tsinda EK, Bouba Y, Mmbando GS, Kong JD. COVID-19 pandemic related research in Africa: bibliometric analysis of scholarly output, collaborations and scientific leadership. Int J Env Res Pub He. 2021;18(14):7273. doi:10.3390/ijerph18147273.
   PubMed Web of Science ®Google Scholar
• Feng X, Martynov I, Suttkus A, Lacher M, Mayer S. Publication trends and global collaborations on esophageal atresia research: a bibliometric study. Eur J Pediatr Surg. 2021;31(2):164–71. doi:10.1055/s-0040-1702223.
   PubMedGoogle Scholar
• Si Y. Co-authorship in energy justice studies: assessing research collaboration through social network analysis and topic modeling. Energy Strateg Rev. 2022;41:100859. doi:10.1016/j.esr.2022.100859.
   Web of Science ®Google Scholar
• Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland W-H, Porrot F, Staropoli I, Lemoine F, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671. doi:10.1038/s41586-021-04389-z.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657. doi:10.1038/s41586-021-04385-3.
   PubMed Web of Science ®Google Scholar
• University L. CWTS Leiden Ranking. 2023. [accessed 2023. Oct 12 Jan 1]. https://www.leidenranking.com/information/universities.
   Google Scholar
• Opricovic S, Tzeng GH. Compromise solution by MCDM methods: a comparative analysis of VIKOR and TOPSIS. Eur J Oper Res. 2004;156(2):445–55. doi:10.1016/S0377-2217(03)00020-1.
   Web of Science ®Google Scholar
• Chen CT. Extensions of the TOPSIS for group decision-making under fuzzy environment. Fuzzy Set Syst. 2000;114(1):1–9. doi:10.1016/S0165-0114(97)00377-1.
   Web of Science ®Google Scholar
• Shih H, Shyur H, Lee ES. An extension of TOPSIS for group decision making. Math Comput Model. 2007;45(7–8):801–13. doi:10.1016/j.mcm.2006.03.023.
   Web of Science ®Google Scholar
• Zhi-Hong Z, Yi Y, Jing-Nan S. Entropy method for determination of weight of evaluating indicators in fuzzy synthetic evaluation for water quality assessment. J Environ Sci. 2006;18(5):1020–3. doi:10.1016/S1001-0742(06)60032-6.
   Google Scholar
• Meng X, Guo M, Gao Z, Kang L. Interaction between travel restriction policies and the spread of COVID-19. Transp Policy. 2023;136:209–27. doi:10.1016/j.tranpol.2023.04.002.
   PubMed Web of Science ®Google Scholar
• Girum T, Lentiro K, Geremew M, Migora B, Shewamare S, Shimbre MS. Optimal strategies for COVID-19 prevention from global evidence achieved through social distancing, stay at home, travel restriction and lockdown: a systematic review. Arch Public Health. 2021;79(1):1–150. doi:10.1186/s13690-021-00663-8.
   PubMed Web of Science ®Google Scholar
• Goncalves A, Porto BL, Rodolfo B, Faggion CM Jr, Agostini BA, Sousa-Neto MD, Moraes RR. Brazilian articles in top-tier dental journals and influence of international collaboration on citation rates. Braz Dent J. 2019;30(4):307–16. doi:10.1590/0103-6440201902826.
   PubMedGoogle Scholar
• Leydesdorff L, Bornmann L, Wagner CS. The relative influences of government funding and international collaboration on citation impact. J Assoc Inf Sci Tech. 2019;70(2):198–201. doi:10.1002/asi.24109.
   PubMed Web of Science ®Google Scholar
• Roncati L, Roncati M. Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic. J Public Health Pol. 2021;42(3):518–21. doi:10.1057/s41271-021-00299-6.
   PubMed Web of Science ®Google Scholar
• Lamb YN. BNT162b2 mRNA COVID-19 vaccine: first approval. Drugs. 2021;81(4):495–501. doi:10.1007/s40265-021-01480-7.
   PubMed Web of Science ®Google Scholar
• Peng L, Renauer PA, Okten A, Fang Z, Park JJ, Zhou X, Lin Q, Dong MB, Filler R, Xiong Q, et al. Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2. Cell Rep Med. 2022;3(5):100634. doi:10.1016/j.xcrm.2022.100634.
   PubMedGoogle Scholar
• Fang Z, Peng L, Filler R, Suzuki, K, McNamara, A, Lin, Q, Renauer, PA, Yang, L, Menasche, B, Sanchez, A, et al. Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2. Nat Commun. 2022;13(1).
   Web of Science ®Google Scholar
• Fang Z, Monteiro VS, Hahn AM, Grubaugh ND, Lucas C, Chen S. Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5. Cell Discov. 2022;8(1):108. doi:10.1038/s41421-022-00473-4.
   PubMed Web of Science ®Google Scholar
• Li M, Ren J, Si X, Sun Z, Wang P, Zhang X, Liu K, Wei B. The global mRNA vaccine patent landscape. Hum Vaccin Immunother. 2022;18(6):2095837. doi:10.1080/21645515.2022.2095837.
   PubMed Web of Science ®Google Scholar
• Alberer M, Gnad-Vogt U, Hong HS, Mehr KT, Backert L, Finak G, Gottardo R, Bica MA, Garofano A, Koch SD, et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet. 2017;390(10101):1511–20. doi:10.1016/S0140-6736(17)31665-3.
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–78. doi:10.1016/S0140-6736(20)31604-4.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens S, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1.
   PubMed Web of Science ®Google Scholar
• Wan E, Chui C, Wang Y, Ng VWS, Yan VKC, Lai FTT, Li X, Wong CKH, Chan EWY, Wong CSM, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393. doi:10.1016/j.lanwpc.2022.100393.
   PubMedGoogle Scholar
• Xiong X, Wong C, Au I, Lai FTT, Li X, Wan EYF, Chui CSL, Chan EWY, Cheng FWT, Lau KTK, et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid. 2022;32(5):505–14. doi:10.1089/thy.2021.0684.
   PubMed Web of Science ®Google Scholar
• Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, et al. COVID-19 vaccines and thrombosis—roadblock or dead-end street? Biomolecules. 2021;11(7):1020. doi:10.3390/biom11071020.
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, Morales M, Ziv T, Shorer Arbel Y, Scarfò L, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165–73. doi:10.1182/blood.2021011568.
   PubMed Web of Science ®Google Scholar
• Nakagama Y, Candray K, Kaku N, Komase Y, Rodriguez-Funes M-V, Dominguez R, Tsuchida T, Kunishima H, Nagai E, Adachi E, et al. Antibody avidity maturation following recovery from infection or the booster vaccination grants breadth of SARS-CoV-2 neutralizing capacity. J Infect Dis. 2023;227(6):780–7. doi:10.1093/infdis/jiac492.
   PubMed Web of Science ®Google Scholar
• Sugiyama A, Kurisu A, Nagashima S, Hando K, Saipova K, Akhmedova S, Abe K, Imada H, Hussain MRA, Ouoba S, et al. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers. Sci Rep-UK. 2022;12(1):16294. doi:10.1038/s41598-022-20747-x.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–92. doi:10.1016/S1473-3099(20)30843-4.
   PubMed Web of Science ®Google Scholar
• Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc1932.
   PubMed Web of Science ®Google Scholar
• Kraemer M, Yang CH, Gutierrez B, Wu C-H, Klein B, Pigott DM, du Plessis L, Faria NR, Li R, Hanage WP, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–7. doi:10.1126/science.abb4218.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials. Study to describe the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals. 2023 Feb 28 2020.
   Google Scholar
• Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Polack FP, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. New Engl J Med. 2021;385(19):1761–73. doi:10.1056/NEJMoa2110345.
   PubMed Web of Science ®Google Scholar
• Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmaco. 2021;25:1663–9.
   PubMed Web of Science ®Google Scholar
• Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, Datir R, Collier DA, Albecka A, Singh S, et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021;599(7883):114. doi:10.1038/s41586-021-03944-y.
   PubMed Web of Science ®Google Scholar
• Parreira MR, Machado KB, Logares R, Diniz-Filho JAF, Nabout JC. The roles of geographic distance and socioeconomic factors on international collaboration among ecologists. Scientometrics. 2017;113(3):1539–50. doi:10.1007/s11192-017-2502-z.
   Web of Science ®Google Scholar
• Petruzzelli AM. The impact of technological relatedness, prior ties, and geographical distance on university-industry collaborations: a joint-patent analysis. Technovation. 2011;31(7):309–19. doi:10.1016/j.technovation.2011.01.008.
   Web of Science ®Google Scholar
• Hou L, Pan Y, Zhu JJH. Impact of scientific, economic, geopolitical, and cultural factors on international research collaboration. J Informetr. 2021;15(3):101194. doi:10.1016/j.joi.2021.101194.
   Web of Science ®Google Scholar
• Tenzer H, Pudelko M, Harzing A. The impact of language barriers on trust formation in multinational teams. J Int Bus Stud. 2014;45(5):508–35. doi:10.1057/jibs.2013.64.
   Web of Science ®Google Scholar
• Hwang K. Effects of the language barrier on processes and performance of international scientific collaboration, collaborators’ participation, organizational integrity, and interorganizational relationships. Sci Commun. 2013;35(1):3–1. doi:10.1177/1075547012437442.
   Web of Science ®Google Scholar
• Peltokorpi V, Clausen L. Linguistic and cultural barriers to intercultural communication in foreign subsidiaries. Asian Bus Manag. 2011;10(4):509–28. doi:10.1057/abm.2011.20.
   Web of Science ®Google Scholar
• Yuan L, Hao Y, Li M, Bao C, Li J, Wu D. Who are the international research collaboration partners for China? A novel data perspective based on NSFC grants. Scientometrics. 2018;116(1):401–22. doi:10.1007/s11192-018-2753-3.
   Web of Science ®Google Scholar
• Martin-Martin A, Thelwall M, Orduna-Malea E, Lopez-Cozar ED. Google scholar, Microsoft academic, Scopus, dimensions, Web of science, and open citations’ COCI: a multidisciplinary comparison of coverage via citations. Scientometrics. 2021;126(1):871–906. doi:10.1007/s11192-020-03690-4.
   PubMed Web of Science ®Google Scholar
• Singh VK, Singh P, Karmakar M, Leta J, Mayr P. The journal coverage of Web of science, Scopus and dimensions: a comparative analysis. Scientometrics. 2021;126(6):213–28. doi:10.1007/s11192-021-03948-5.
   Web of Science ®Google Scholar